Recent consultations NPPG has responded to (Dec 2015 – Oct 2017)
Attention deficit hyperactivity disorder (update). December 2015. Scoping workshop attended by one NPPG member.
Mental health problems in people with a learning disability. April 2016.
Scoping Workshop and Consultation Invitation (Professional): Urea cycle disorders – glycerol phenylbutyrate [ID942]. April 2016. One specialist NPPG member attended the scoping workshop.
Rheumatoid Arthritis scope. One NPPG member selected to attend scoping workshop in April 2016.
Renal Replacement scoping workshop. Volunteers requested, and one NPPG member selected to attend the workshop. May 2016.
Oral health promotion in the community (Quality Standard). June 2016.
End of life care for infants, children and young people. August 2016.
Vaccine uptake in under 19s (Quality Standard). September 2016.
Asthma management: draft guideline consultation. February 2017.
Specialist Neonatal Care draft scope consultation. February 2017.
Parenteral nutrition in neonates. Scoping workshop attended March 2017 by NPPG member. Successful representation for paediatric pharmacist on guideline committee. Draft scope consultation. April 2017.
End of life care for infants, children and young people: Quality standard consultation. May 2017.
Cystic fibrosis – diagnosis and management. June 2017.
Sinusitis (acute) antimicrobial prescribing. June 2017.
Sore throat (acute): antimicrobial prescribing: Draft guidance consultation. August 2017.
Attention deficit hyperactivity disorder (update). October 2017.
Otitis media (acute): antimicrobial prescribing. October 2017.
We will be responding to the reflection paper on the use of extrapolation in the development of medicines for paediatrics over the next months
Comments submitted on Changes to Orphan Drugs article. February 2016
ICH E11(R1) guideline on clinical investigation of medicinal products in the pediatric population. April 2017
Never Events policy and framework review 2016 – circulated to members for individual comment
Specialised Services clinical commissioning policies and service specification – 3rd wave. Comments submitted on ivacaftor and aztreonam lysine in cystic fibrosis. March 2016.
Engagement on proposed revisions to Clinical Reference Groups in specialised commissioning. March 2016.
Specialised Services clinical commissioning policies and service specification – 7th wave. Comments submitted on obesity in surgery. April 2016.
Developing a method to assist investment decisions in specialised commissioning. May 2016.
Commissioning Policies: Funding of Treatment outside of Clinical Commissioning Policy or Mandated NICE Guidance – A. In-year service development, B. Individual Funding Requests, C. Funding for experimental and unproven treatments, D. Continuing funding after clinical trials. October 2016. Circulated to members for individual comment.
Consultation on the Clinical Commissioning Policy Proposition: Commissioning Medicines in Children. October 2016. Circulated to members for individual comment.
Consultation on standards for pharmacy professionals. June 2016. Circulated to members for individual comment.
Continuing Professional Development: 2016 consultation – circulated to members for individual comment
Specials Guidance for Prescribers. December 2015.
Professional standards for hospital pharmacy services. September 2017.
We will be responding to the draft Professional Guidance on the Safe and Secure Handling of Medicines in the coming months
Consultation on prescribing and standards for medicines management. September 2017.
British guideline on the management of asthma. April 2016.